Hemoglobin testing market to reach $4.28 billion by 2030

The hemoglobin testing market is projected to grow from $2.79 billion in 2025 to $4.28 billion by 2030, driven by rising chronic disease screening, home testing adoption and broader use of point-of-care diagnostics. Asia-Pacific is expected to remain the largest and fastest-growing regional market.

Why it matters: - Hemoglobin testing is a core diagnostic tool for monitoring oxygen-carrying capacity in blood and managing conditions such as anemia and diabetes. - Growth in testing demand signals broader expansion in routine screening, preventive care and decentralized diagnostics.

What happened: - The hemoglobin testing market is projected to rise from $2.79 billion in 2025 to $3.03 billion in 2026. - The market is expected to reach $4.28 billion by 2030, implying a 9.0% CAGR over the forecast period. - The Business Research Company released the market analysis on Aug. 10, 2026. - The report includes a free sample and the full market report through the company’s website: More information and the full report.

The details: - Historical growth from 2025 to 2026 reflects an 8.7% CAGR. - The report links past growth to routine blood testing, anemia screening programs, higher hospital diagnostic workloads, affordable test kits and public health efforts. - Future growth is tied to decentralized diagnostics, home testing devices, digital health monitoring, early disease detection and improved diagnostic precision. - The report highlights point-of-care hemoglobin tests, portable analyzers, rapid blood screening methods, home-based testing and preventive health as major trends. - Hemoglobin testing measures hemoglobin levels in blood. - Hemoglobin carries oxygen from the lungs to tissues and organs. - Accurate hemoglobin measurement is important for diagnosing and managing health conditions. - Diabetes is a major driver because HbA1c testing is used to monitor glucose levels in diabetic patients. - The American Diabetes Association recognizes HbA1c as a reliable alternative to fasting blood glucose tests. - The US Census Bureau said in November 2022 that more than 34 million Americans had diabetes and 88 million more were at risk. - The IDF Diabetes Atlas 10th edition said diabetes affected 536,000 people in Belgium in 2021, with projections of 642,800 by 2030 and 783,700 by 2045. - Asia-Pacific was the largest regional market in 2025. - Asia-Pacific is expected to remain the fastest-growing region through the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

Between the lines: - The forecast suggests hemoglobin testing is shifting beyond hospital labs toward faster, more portable and consumer-facing formats. - Rising diabetes prevalence gives the market a durable demand base because hemoglobin-related monitoring is tied to chronic disease management. - The regional lead for Asia-Pacific points to both population scale and expanding diagnostic access across the region.

What's next: - Market growth will likely track adoption of home testing, portable analyzers and digital monitoring systems. - Continued screening for chronic disease and anemia should keep testing volumes elevated through 2030. - The company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, market hotspot infographics and updated graphics and tables. - More information is available through the company’s sample page and full report links.